Stockreport

Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ... [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Dupixent Global Net Sales: $4.9 billion in Q4 2025, $17.8 billion for the full year 2025. Libtayo Global Net Sales: $425 million in Q4 2025, $1.45 billion for the ful [Read more]